Literature DB >> 10843975

Utilization in COPD: patient characteristics and diagnostic evaluation.

D W Mapel1, M A Picchi, J S Hurley, F J Frost, H V Petersen, V M Mapel, D B Coultas.   

Abstract

STUDY
OBJECTIVES: Information on current practices of COPD diagnosis and treatment is needed to identify opportunities for improving care. This study describes the clinical characteristics and diagnostic evaluations of COPD patients in a health maintenance organization (HMO) and a university-affiliated county medical center (UMC).
DESIGN: Cross-sectional survey performed in a 174,484-member regional HMO and in The University of New Mexico Hospitals and Clinics (UNMH). PATIENTS: Two hundred COPD patients from each system randomly selected from administrative databases based on discharge diagnoses.
RESULTS: COPD patients in the UMC, compared to those in the HMO, were younger (mean age, 59.3 vs 66.9 years, respectively), were more likely to be using home oxygen (33% vs 20%, respectively), and had fewer chronic medical conditions (mean number of conditions, 3.1 vs 3.7, respectively) (p < 0.01 for all differences). Approximately half of the COPD patients in both groups continued to smoke cigarettes during the study year. Only 38% of patients in the HMO and 42% in the UNMH system had spirometry results documented in their medical records.
CONCLUSIONS: The demographic and clinical characteristics of the COPD patients in these two health-care systems were very different, but smoking status and utilization of diagnostic tests were similar. The diagnosis of COPD in most patients was based only on a history of chronic respiratory symptoms and smoking; spirometry often was not used to confirm the diagnosis. An increased emphasis on smoking cessation and more effective utilization of spirometry are needed to improve the management of COPD in these health-care systems.

Entities:  

Mesh:

Year:  2000        PMID: 10843975     DOI: 10.1378/chest.117.5_suppl_2.346s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

1.  Exploring variables associated with medication non-adherence in patients with COPD.

Authors:  Anan S Jarab; Tareq L Mukattash
Journal:  Int J Clin Pharm       Date:  2019-08-30

2.  Admissions with chronic obstructive pulmonary disease after publication of national guidelines.

Authors:  M G Kelly; J S Elborn
Journal:  Ir J Med Sci       Date:  2002 Jan-Mar       Impact factor: 1.568

Review 3.  Chronic Obstructive Pulmonary Disease and the Risk of Stroke.

Authors:  Ann D Morgan; Chetna Sharma; Kieran J Rothnie; James Potts; Liam Smeeth; Jennifer K Quint
Journal:  Ann Am Thorac Soc       Date:  2017-05

4.  COPD is frequent in conditions of comorbidity in patients treated with various diseases in a university hospital.

Authors:  Akira Yamasaki; Kiyoshi Hashimoto; Yasuyuki Hasegawa; Ryota Okazaki; Miki Yamamura; Tomoya Harada; Shizuka Ito; Soichiro Ishikawa; Hiroki Takami; Masanari Watanabe; Tadashi Igishi; Yuji Kawasaki; Eiji Shimizu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-10-05

Review 5.  Underrecognized comorbidities of chronic obstructive pulmonary disease.

Authors:  Joanna Miłkowska-Dymanowska; Adam J Białas; Anna Zalewska-Janowska; Paweł Górski; Wojciech J Piotrowski
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-15

Review 6.  New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses.

Authors:  Douglas W Mapel; Melissa H Roberts
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

7.  Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD.

Authors:  Douglas W Mapel; Jenõ P Marton
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-03-15

Review 8.  Adherence to disease management programs in patients with COPD.

Authors:  Johnson George; David C M Kong; Kay Stewart
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

9.  Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea.

Authors:  Kyungsoo Chung; Kyungjoo Kim; Jiye Jung; Kyungwon Oh; Yeonmok Oh; Sekyu Kim; Jinhee Kim; Youngsam Kim
Journal:  BMC Pulm Med       Date:  2014-02-27       Impact factor: 3.317

10.  Clinical and individual factors associated with smoking quit attempts among adults with COPD: do factors vary with regard to race?

Authors:  Dana S Mowls; Vinay K Cheruvu; Melissa D Zullo
Journal:  Int J Environ Res Public Health       Date:  2014-04-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.